Solventum Corporation (LON:0AD1)
London
· Delayed Price · Currency is GBP · Price in USD 74.63
+8.38 (12.65%)
At close: May 13, 2025
Solventum Revenue
Solventum had revenue of $2.07B USD in the quarter ending March 31, 2025, with 2.68% growth. This brings the company's revenue in the last twelve months to $8.31B, up 1.29% year-over-year. In the year 2024, Solventum had annual revenue of $8.25B with 0.70% growth.
Revenue (ttm)
$8.31B
Revenue Growth
+1.29%
P/S Ratio
1.49
Revenue / Employee
$377.64K
Employees
22,000
Market Cap
9.59B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.25B | 57.00M | 0.70% |
| Dec 31, 2023 | 8.20B | 67.00M | 0.82% |
| Dec 31, 2022 | 8.13B | -41.00M | -0.50% |
| Dec 31, 2021 | 8.17B | 890.00M | 12.22% |
| Dec 31, 2020 | 7.28B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| HSBC Holdings | 44.89B |
| Shell | 217.54B |
| Unilever | 50.25B |
| British American Tobacco p.l.c. | 25.87B |
| Rio Tinto Group | 42.86B |
| Rolls-Royce Holdings | 18.91B |
| RELX PLC | 9.43B |